Xiao Shao

An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors

Rui Wang, Chan Gao, Megan Raymond et al. · Clinical Cancer Research · 2019 · 43 citations

Medicine, Oncology, Pharmacology +17

A Machine‐Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced Melanoma

Rui Wang, Xiao Shao, Junying Zheng et al. · Clinical Pharmacology & Therapeutics · 2019 · 30 citations

Medicine, Immunology, Oncology +17

Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma

Rui Wang, Junying Zheng, Xiao Shao et al. · Journal for ImmunoTherapy of Cancer · 2019 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Mating strategies in Chinese culture: female risk avoiding vs. male risk taking

Wen Shan, Hunter Morgan Davis, Kaiping Peng et al. · Evolution and Human Behavior · 2011 · 22 citations

Life Sciences, Gender Studies, Social Psychology +13

Abstract LB-127: From bench to bedside: Exploring OX40 receptor modulation in a phase 1/2a study of the OX40 costimulatory agonist BMS-986178 ± nivolumab (NIVO) or ipilimumab (IPI) in patients with advanced solid tumors

Rui Wang, Feng Yan, Ed Hilt et al. · Cancer Research · 2018 · 12 citations

Life Sciences, Immunology, Oncology +17